EORTC protocol 08983

Phase III study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma.
Trial StatusAll trial activities ended
DatesDate of activation: 26-Nov-99
Closed on : 06-Jan-03
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size240
Number of steps1
DrugCisplatin
Raltitrexed
Study StaffGiuseppe Giaccone (Study Coordinator) - National Cancer Institute - National Institute of Health, Bethesda
Christian Manegold (Study Coordinator) - UniversitaetsMedizin Mannheim, Mannheim
Jan Van Meerbeeck (Study Coordinator) - Universitair Ziekenhuis Antwerpen, Edegem
Type of cancerMesothelioma
Participating GroupsEORTC Lung Cancer Group(Coordinating Group)
NCIC Clinical Trial Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00004920
EudraCT
Back to Protocol section